The Top Line

The Top Line offers PR-friendly access to senior pharma/biotech leaders and market-heavy topics. Booking guests delivers credibility and industry visibility for healthcare brands, with discussable angles on FDA outcomes, AI governance, and drug development trends.

100 episodes, Weekly, 4.1 rating

<1k, Male, USA

Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning. 

Fraiser Kansteiner

Business News, News, Business, Health & Fitness, Medicine, Science, Technology

MD, DO, PhD, or senior life-sciences executive (CEO/CSO/CMO/VP)

FDA approvals or pivotal research breakthroughs, leadership roles in pharma/biotech, speaking engagements at major conferences, public thought leadership in life sciences

Brian Hilberdink - BI US Market Strategy, FDA Approvals For Idiopathic Pulmonary Fibrosis And Lung Cancer, BI US Commercialization Push, Marie Flanagan - AI Governance In Healthcare, Safety And Accountability, Human Oversight, Transparency, Ben Adams - Week's Headlines, Pharma Policy Updates, Market Dynamics, Freda Lewis-Hall - Trust In Pharma, Patient Engagement, AI And Omnichannel Outreach, Robert Abel - Ai-driven Drug Discovery, Computational Drug Discovery, Protein Structure Prediction

pharma, biotech, drug development, FDA approvals, gene therapy, hemophilia, AI in healthcare, drug safety, regulatory affairs, commercialization